コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tify selective peptide inhibitors of protein Tyr kinases.
2 substrate sequence specificity of all human Tyr kinases.
3 ase, stk encodes a eukaryotic-like tyrosine (Tyr) kinase.
4 sion of the peptide inhibited ZAP-70 protein Tyr kinase activity by competing with protein substrates
5 tein kinase substrate in vitro This dual Thr-Tyr kinase activity is also observed for a eukaryotic du
7 he Ser/Thr kinase activity of the MAP3K into Tyr kinase activity of the central dual specificity MAP2
8 rocessing through activation of its receptor Tyr kinase activity, and they suggest possible engagemen
9 ostin AG1478), a selective inhibitor of EGFR Tyr kinase activity, blocked EGFR and ERK activation by
12 Human biliverdin reductase (hBVR), a Ser/Thr/Tyr kinase and intracellular scaffold/bridge/anchor, is
14 The simultaneous activation of all receptor Tyr kinases and nonreceptor Tyr kinases leads to complex
15 parison of the sequence specificities of the Tyr kinases and the SH2 phosphotyrosine (pTyr)-binding d
16 humans, suggesting that the fidelity between Tyr kinases and their protein substrate sequences has be
18 s kinase 3 (Jak3) is a cytoplasmic tyrosine (Tyr) kinase associated with the interleukin-2 (IL-2) rec
19 results in the stimulation of intracellular Tyr kinase-based signaling cascades and cellular activat
20 a(1)-integrin inhibited Abeta stimulation of Tyr kinase-based signaling cascades in both THP-1 monocy
23 toring the effects of chemical inhibition of Tyr kinase CK2 or by mutating the phosphorylation site.
24 dentified an IL-2-JAK-independent SRC family Tyr-kinase-controlled signaling network that regulates a
26 that Y155 is phosphorylated in vitro by the Tyr kinase domain of epidermal growth factor (EGF) recep
27 composed of a dual specificity (Ser/Thr and Tyr) kinase domain tethered to a calmodulin-like domain
30 that the intrinsic substrate specificity of Tyr kinases has remained fundamentally unchanged from wo
32 ctase (hBVR) is a recently described Ser/Thr/Tyr kinase in the MAPK insulin/insulin-like growth facto
34 Human biliverdin reductase (hBVR), a Ser/Thr/Tyr kinase, inhibits apoptosis by reducing biliverdin-IX
37 of all receptor Tyr kinases and nonreceptor Tyr kinases leads to complex cytoprotective responses in
38 d-binding domain, inhibition of the receptor Tyr kinase-mediating receptor activation, and overexpres
39 Cell lines dependent on the activation of Tyr kinase mitogen receptor targets of the resorcylic ac
40 tein that suppresses signaling from receptor Tyr kinases of the epidermal growth factor receptor/ErbB
41 mains, phosphorylated by protein Ser/Thr- or Tyr-kinases or mediate specific interactions with protei
42 alpha selectively mediates activation of the Tyr kinase Pyk2 and GTPase Rac1 to regulate barrier func
43 at acts as a positive transducer of receptor Tyr kinase (RTK) signaling, particularly the Ras-REK and
45 pecificities of many families of Ser/Thr- or Tyr-kinases, SH2, SH3, PDZ, 14-3-3 and PTB domains, toge
46 specificities accurately identifies specific Tyr kinases that are dysregulated in cells after stimula
48 typically have more than 50 distinct protein Tyr kinases that catalyse the phosphorylation of thousan